Dr. Jeff Rytlewski specializes in the care of patients with soft tissue and bone sarcomas, with expertise in the use of systemic therapies, including chemotherapy, targeted therapy, immunotherapy, and clinical trials. He is dedicated to providing compassionate care and helping patients understand their diagnosis and treatment to help make informed decisions throughout their cancer journey.
Because sarcomas are rare and complex cancers, he believes patients deserve access to specialized, multidisciplinary care and the chance to participate in innovative clinical research when appropriate for their care.
His research focuses on advancing treatments for sarcomas through clinical trials, including early phase clinical trials. He aims to improve outcomes from sarcoma by bringing promising new therapies and therapeutic strategies from the laboratory to clinic.
He completed his medical degree at Indiana University, followed by residency and research training at the University of Iowa, and completed fellowship at the University of Colorado.
